Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
COP9 signalosome complex subunit 5 (CSN5), also known as JAB1, is a zinc-dependent metalloprotease and isopeptidase that forms the catalytic core of the COP9 signalosome (CSN), an evolutionarily conserved multi-protein complex involved in the regulation of ubiquitin-proteasome-mediated protein degradation via deneddylation of cullin-RING ubiquitin ligases[1][3][4][5][8]. CSN5 contains a signature Jab1/MPN/Mov34 (JAMM) motif that chelates metal ions and confers catalytic activity[1][7]. CSN5 plays a critical role in cell cycle progression, cell survival, and transcription regulation and is considered an oncogene due to its frequent overexpression in human cancers and association with poor prognosis[2]. In addition to its function within the CSN, CSN5 may also operate as a monomer or in smaller complexes and interacts with several key cell cycle and signaling proteins, including CDK2 and c-Jun[2]. Its biological and biochemical importance, essential roles in development, and implication as a cancer driver make it a significant therapeutic target, though safety concerns exist due to its essential cellular functions[2][4][7].
Inhibition of CSN5’s isopeptidase/deneddylase catalytic activity (primarily at the JAMM motif)[7]. Inhibition of protein deneddylation, leading to impaired function of cullin-RING ubiquitin ligases and altered protein degradation[7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on COP9 signalosome complex subunit 5 (CSN5).